A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors.

Volume: 145, Issue: 3, Pages: 639 - 648
Published: Aug 1, 2019
Abstract
The advent of immune checkpoint-inhibitors (CPI) has transformed treatment for several cancer types. This review was performed to assess the rate of adverse events (AEs) associated with the use of CPI, alone or in combinations. A review of AEs reporting quality was also performed. All publications of Randomized Clinical Trials (RCTs) assessing CPI published before December 2017 were included. To investigate the quality of AEs reporting, a set of...
Paper Details
Title
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors.
Published Date
Aug 1, 2019
Volume
145
Issue
3
Pages
639 - 648
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.